Detalles de la búsqueda
1.
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.
Circulation
; 149(5): 354-362, 2024 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850379
2.
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.
Lancet
; 392(10155): 1311-1320, 2018 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293769
3.
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Eur Heart J
; 34(40): 3117-27, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23999456
4.
Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15.
J Atheroscler Thromb
; 31(6): 876-903, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38220186
5.
Efficacy and Safety of Inclisiran in Asian Patients: Results From ORION-18.
JACC Asia
; 4(2): 123-134, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38371290
6.
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial.
Cardiovasc Res
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753448
7.
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
JAMA
; 309(11): 1125-35, 2013 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23478743
8.
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects.
J Clin Lipidol
; 17(1): 181-188, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529659
9.
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial.
Lancet Diabetes Endocrinol
; 11(2): 109-119, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620965
10.
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials.
J Am Coll Cardiol
; 82(24): 2251-2261, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057066
11.
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease.
Open Heart
; 9(2)2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36252994
12.
Reply: Evaluation of the Inclisiran Safety in High-Risk Populations.
J Am Coll Cardiol
; 83(13): e129, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538207
13.
Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies.
Endocrine
; 60(1): 65-72, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29116540
14.
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
Eur J Heart Fail
; 17(1): 98-108, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25597870
15.
Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.
Eur J Heart Fail
; 15(11): 1236-44, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23787721
16.
Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients.
J Clin Hypertens (Greenwich)
; 13(7): 506-16, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21762364
17.
Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension.
J Clin Hypertens (Greenwich)
; 12(10): 765-75, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21029339
Resultados
1 -
17
de 17
1
Próxima >
>>